CRH Medical (CRHM) Reports Q3 Revenue Beat

CRH Medical (NYSE: CRHM) reported Q3 revenues for the quarter came in at $28.73 million versus the consensus estimate of $27.81 million.

Edward Wright, Chief Executive Officer of CRH commented, "We are very pleased with our strong third quarter and year to date financial and operating results. Revenue growth and operating margins remain very strong, with year to date adjusted shareholder EBITDA more than $25 million. This shows the impressive strength of our business model and ability to execute especially considering the impact of the CMS changes that went into effect on January 1, 2018." Mr. Wright continued, "We are also excited to announce our most recent MAC partnership with Digestive Health Specialists. This transaction follows the successful execution of our first MAC acquisition, which resulted in a transaction in July 2018 and furthers our goal of becoming the preeminent provider of GI anesthesia. Our infrastructure and expertise in assisting gastroenterology anesthesia practices plays a role in better patient care."

For earnings history and earnings-related data on CRH Medical (CRHM) click here.

You May Also Be Interested In

• Nanometrics (NANO) Issues Business Update, Reports FY23 Results
• QuantumScape (QS) Misses Q1 EPS by 1c
• National Capital Bancorp, Inc. (NACB) Reports Q1 Revenue